Intimation of Resignation Of Non Executive Independent Director under Regulation 30 of the SEBI(LODR) Regulation, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mrs. Deepika Krishnan Iyer (DIN: 10515778) has resigned as a Non-Executive Independent Director of Welcure Drugs & Pharmaceuticals Ltd, effective from the close of business hours on August 6, 2025. The reason cited is 'pre-occupation' (personal/professional commitments). She has confirmed that there are no other material reasons for her resignation beyond what is stated in her letter. The Board has acknowledged her contribution during her tenure. The letter is signed by Chintan Didawala Ganpat, Managing Director & CFO.
This is a routine independent director exit due to personal pre-occupation and carries no governance red flags. Shareholders should monitor whether the company appoints a replacement within the regulatory timeline to maintain the required board composition; no immediate material impact on stock price is expected.